Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Suzette Girgis"'
Autor:
Clarissa M. Uhlar, Jesús F. San-Miguel, Lotfi Benboubker, Saad Z. Usmani, Maria-Victoria Mateos, Alfred L. Garfall, Hareth Nahi, Rachel Kobos, Philippe Moreau, Rian Van Rampelbergh, Britta Besemer, Amrita Krishnan, Lionel Karlin, Jenna D. Goldberg, Laura Rosiñol, Suzette Girgis, Joaquin Martinez-Lopez, Nizar J. Bahlis, Niels W.C.J. van de Donk, Ajay K. Nooka, Albert Oriol, Lixia Pei, Thomas Martin, Arnob Banerjee, Raluca Verona, Yunsi Olyslager, Mindy Jaffe, Ajai Chari, Danielle Trancucci, Surbhi Sidana, Tara Stephenson, Rakesh Popat
Publikováno v:
Blood. 138:896-896
Introduction: Teclistamab (JNJ-64007957) is a T-cell redirecting, bispecific IgG4 antibody that targets both B-cell maturation antigen (BCMA) and CD3 receptors to induce T-cell mediated cytotoxicity of BCMA-expressing myeloma cells. Teclistamab is un
Autor:
Paula Rodriguez-Otero, Amrita Krishnan, Brandi Hilder, Elham Askari, Xuewen Ma, Shiyi Yang, Ajai Chari, Jenna D. Goldberg, Luciano J. Costa, Maria-Victoria Mateos, Suzette Girgis, Monique C. Minnema, Jesus G. Berdeja, Niels W.C.J. van de Donk, Jeffery S. Russell, Albert Oriol, Raluca Verona
Publikováno v:
Blood. 138:158-158
Introduction: Despite recent advances in treatment, patients with multiple myeloma (MM) continue to relapse. G protein-coupled receptor family C group 5 member D (GPRC5D) is a promising target for immunotherapy in patients with MM due to its high exp
Autor:
Brandi Hilder, Paula Rodriguez, Albert Oriol, Jesus G. Berdeja, Maria-Victoria Mateos, Suzette Girgis, Jeffery S. Russell, Raluca Verona, Thomas J. Prior, Monique C. Minnema, Ajai Chari, Niels W.C.J. van de Donk, Elham Askari, Amrita Krishnan, Jenna D. Goldberg
Publikováno v:
Blood. 136:40-41
Despite improved outcomes with current MM treatments, most patients (pts) will develop refractory disease, highlighting the need for novel treatments. GPRC5D is an orphan receptor whose transcript is highly expressed in primary MM cells but has gener